Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,747.78
(
0.72%
)
US TECH 100
24,132.80
(
0.49%
)
Dow Jones
47,389.52
(
0.94%
)
Brent Oil
99.20
(
0.91%
)
Bitcoin
73,848.20
(
-1.32%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ThomasS post# 62153

Wednesday, 04/30/2008 11:45:11 PM

Wednesday, April 30, 2008 11:45:11 PM

Post# of 257251
>MNTA believes their version of Lovenox will be a de facto authorized generic, fully substitutable with Lovenox at the pharmacy level.<

If approved, automatic substitutability is a given because the filing is an ANDA rather than a 505b2. In other words, MNTA/Sandoz will be able to capture substantial market share without spending even a dime on marketing.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now